Moloney Securities Asset Management LLC purchased a new stake in Grail, Inc. (NASDAQ:GRAL – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 31,336 shares of the company’s stock, valued at approximately $559,000.
Several other large investors have also recently added to or reduced their stakes in the company. FNY Investment Advisers LLC acquired a new position in Grail during the 4th quarter worth about $26,000. Wilmington Savings Fund Society FSB bought a new position in shares of Grail in the fourth quarter worth about $64,000. China Universal Asset Management Co. Ltd. acquired a new position in shares of Grail during the fourth quarter worth approximately $127,000. Perigon Wealth Management LLC bought a new stake in shares of Grail during the fourth quarter valued at approximately $260,000. Finally, B & T Capital Management DBA Alpha Capital Management acquired a new stake in shares of Grail in the fourth quarter valued at approximately $387,000.
Insiders Place Their Bets
In related news, CFO Aaron Freidin sold 30,452 shares of the stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $14.02, for a total value of $426,937.04. Following the sale, the chief financial officer now directly owns 268,277 shares in the company, valued at $3,761,243.54. This trade represents a 10.19 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link.
Grail Stock Up 3.6 %
Grail (NASDAQ:GRAL – Get Free Report) last announced its quarterly earnings data on Tuesday, November 12th. The company reported ($3.94) EPS for the quarter. The company had revenue of $28.65 million during the quarter. As a group, research analysts predict that Grail, Inc. will post -65.16 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
Several research analysts have issued reports on GRAL shares. Guggenheim began coverage on Grail in a report on Thursday, October 17th. They set a “neutral” rating on the stock. Wolfe Research assumed coverage on Grail in a report on Friday, November 15th. They issued a “peer perform” rating on the stock. Finally, Morgan Stanley assumed coverage on Grail in a report on Wednesday, November 27th. They set an “equal weight” rating and a $16.00 price objective for the company.
Read Our Latest Stock Report on Grail
Grail Company Profile
GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.
Featured Stories
- Five stocks we like better than Grail
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Merck: 4 No-Brainer Reasons to Buy This Dip
- 3 Dividend Kings To Consider
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Want to see what other hedge funds are holding GRAL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Grail, Inc. (NASDAQ:GRAL – Free Report).
Receive News & Ratings for Grail Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Grail and related companies with MarketBeat.com's FREE daily email newsletter.